Tuesday, April 28, 2026 | 01:22 AM ISTहिंदी में पढें
Glenmark Pharmaceuticals Ltd
Announcement under Regulation 30 (LODR)-Press Release / Media Release
06:37 PM, 2nd Jun 2025
Full Dose - Esclation Data Show Continued High Response Rates and Favourable Safety Profile of ISB 2001 a First-in-Class BCMA x CD38 x CD3 Trispecific Antibody for the Treatment of Relapsed/ Refractory Multiple Myeloma